Cargando…

Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome

Background and Aims: Irritable bowel syndrome (IBS), a functional pain disorder of gut-brain interactions, is characterized by a high placebo response in randomized clinical trials (RCTs). Catechol-O-methyltransferase (COMT) rs4680, which encodes high-activity (val) or low-activity (met) enzyme vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rui-Sheng, Lembo, Anthony J., Kaptchuk, Ted J., Cheng, Vivian, Nee, Judy, Iturrino, Johanna, Rao, Meenakshi, Loscalzo, Joseph, Silvester, Jocelyn A., Hall, Kathryn T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pain Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915627/ https://www.ncbi.nlm.nih.gov/pubmed/35295415 http://dx.doi.org/10.3389/fpain.2021.775386

Ejemplares similares

Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome
por: Vollert, Jan, et al.
Publicado: (2022)

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
por: Ballou, Sarah, et al.
Publicado: (2017)

Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study
por: Haas, Julia W., et al.
Publicado: (2022)

Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome
por: Hall, Kathryn T., et al.
Publicado: (2012)

Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia
por: Singh, Prashant, et al.
Publicado: (2019)

Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
por: Kaptchuk, Ted J., et al.
Publicado: (2010)

Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome
por: Nee, Judy, et al.
Publicado: (2019)

Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice
por: Rastelli, Daniella, et al.
Publicado: (2022)

Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance
por: Orock, Albert, et al.
Publicado: (2021)

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
por: Singh, Prashant, et al.
Publicado: (2022)

Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome
por: Boonma, Prapaporn, et al.
Publicado: (2021)

Episodic Memories Among Irritable Bowel Syndrome (IBS) Patients: An Important Aspect of the IBS Symptom Experience
por: Sayuk, Gregory S., et al.
Publicado: (2022)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome
por: Acosta, Andres, et al.
Publicado: (2016)

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)
por: Chey, William D., et al.
Publicado: (2020)

Placebo by proxy
por: Grelotti, David J, et al.
Publicado: (2011)

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)
por: Chey, William D., et al.
Publicado: (2021)

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
por: Cash, Brooks D., et al.
Publicado: (2017)

Symptom perception, placebo effects, and the Bayesian brain
por: Ongaro, Giulio, et al.
Publicado: (2019)

Placebo, nocebo: Believing in the field of medicine
por: Meissner, Karin
Publicado: (2022)

Editorial: Placebo Effect in Pain and Pain Treatment
por: Bernstein, Michael H., et al.
Publicado: (2022)

Can the Open Label Placebo Rationale Be Optimized?
por: Heiss, Uwe, et al.
Publicado: (2021)

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
por: Dossett, Michelle L., et al.
Publicado: (2015)

Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials
por: Vollert, Jan, et al.
Publicado: (2020)

Historical evolution of the scientific investigation of the placebo analgesic effect
por: Benedetti, Fabrizio
Publicado: (2022)

Emergency department burden of hyperemesis gravidarum in the United States from 2006 to 2014
por: Geeganage, Grace, et al.
Publicado: (2023)

“Maybe I Made Up the Whole Thing”: Placebos and Patients’ Experiences in a Randomized Controlled Trial
por: Kaptchuk, Ted J., et al.
Publicado: (2009)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
por: Shah, Eric, et al.
Publicado: (2014)

Baseline heart rate variability predicts placebo hypoalgesia in men, but not women
por: Krecké, Joy, et al.
Publicado: (2023)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
por: Flik, Carla E, et al.
Publicado: (2017)

Oxidative stress involves phenotype modulation of morbid soreness symptoms in fibromyalgia
por: Hung, Chih-Hsien, et al.
Publicado: (2023)

Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
por: Koechlin, Helen, et al.
Publicado: (2021)

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
por: Lyra, Anna, et al.
Publicado: (2016)

An Exploratory Analysis of the Association Between Catechol-O-Methyltransferase and Response to a Randomized Open-Label Placebo Treatment for Cancer-Related Fatigue
por: Hoenemeyer, Teri W., et al.
Publicado: (2021)

Duloxetine for the Treatment of Chronic Low Back Pain: A Systematic Review of Randomized Placebo-Controlled Trials
por: Hirase, Takashi, et al.
Publicado: (2021)

The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review
por: Estudillo-Guerra, Maria A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qu4v9flssmnihn048ojduvgh3j